Delivery Order SPE2DB22D3301-SPE2DB25FZ1PU
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $12,260.04. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for completion by May 13, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $19,079.79, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is set to be completed by September 9, 2025, with performance occurring at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $15,724.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $12,612.95. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Eliquis 5 mg tablets in a quantity of 60 units, valued at $7,315.22. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract calls for delivery by August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $14,533.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for ultimate completion by September 9, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Eliquis is an...
- The Defense Logistics Agency awarded a $28,687.18 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a $44,666.45 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. Eliquis is a widely prescribed...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1PUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $14,122.32. This is a firm fixed price delivery order issued without a set-aside designation, reflecting open competition for the award. The contract is expected to be completed by September 26, 2025, and performance will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare systems for stroke prevention and blood clot treatment. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's demonstrated capability to fulfill federal procurement requirements through competitive awards reflects its established role in supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 9/25/25 |